Dultz, L. A., Dhar, S., Ogilvie, J. B., Heller, K. S., Bar-Sagi, D., & Patel, K. N. (2013). CLINICAL AND THERAPEUTIC IMPLICATIONS OF SPROUTY2 FEEDBACK DYSREGULATION IN BRAF V600E MUTATION POSITIVE PAPILLARY THYROID CANCER.
Citação norma ChicagoDultz, Linda A., Shumon Dhar, Jennifer B. Ogilvie, Keith S. Heller, Dafna Bar-Sagi, and Kepal N. Patel. CLINICAL AND THERAPEUTIC IMPLICATIONS OF SPROUTY2 FEEDBACK DYSREGULATION IN BRAF V600E MUTATION POSITIVE PAPILLARY THYROID CANCER. 2013.
Citação norma MLADultz, Linda A., et al. CLINICAL AND THERAPEUTIC IMPLICATIONS OF SPROUTY2 FEEDBACK DYSREGULATION IN BRAF V600E MUTATION POSITIVE PAPILLARY THYROID CANCER. 2013.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.